囊性纤维化跨膜传导调节因子在慢阻肺中的作用:呼吸上皮及之外
本综述探讨CFTR获得性功能障碍在慢阻肺中的作用。吸烟是导致CFTR功能受损的主要原因,炎症、细菌产物和活性氧可进一步损害CFTR表达和功能。CFTR功能障碍可能促进气道表面液体稳态紊乱、黏液阻塞、病原体定植和炎症,参与慢阻肺发病和进展,并可能加重肺外共病。CFTR增强剂的开发可能为慢阻肺尤其慢性支气管炎患者带来获益。
要点
- 吸烟是慢阻肺患者CFTR获得性功能障碍的主要原因
- CFTR功能障碍可累及气道、汗腺和肠道,提示全身性缺陷
- CFTR增强剂可能改善组织稳态、减轻炎症并增强宿主防御
核心结论
- CFTR获得性功能障碍可能参与慢阻肺发病和进展,并可能加重肺外共病和疾病负担。
研究设计与样本
- 综述,探讨CFTR功能障碍如何获得及其对慢阻肺患者的潜在影响。
主要发现
- 在慢阻肺患者和吸烟者中,上、下气道、汗腺和肠道均证实CFTR受损。
- 香烟烟雾是CFTR获得性功能障碍的主要原因,炎症、细菌副产物和活性氧可进一步损害CFTR表达和功能。
- CFTR功能障碍可能导致气道表面液体稳态紊乱、气道黏液阻塞、病原体定植和炎症。
- 黏液栓和中性粒细胞炎症促进组织破坏、小气道功能障碍和慢阻肺进展。
临床怎么用
- 关注慢阻肺患者尤其慢性支气管炎患者的CFTR功能障碍,CFTR增强剂可能改善组织稳态、减轻炎症、增强宿主防御并可能减少肺重塑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel for transport of chloride and bicarbonate anions. Functional roles of CFTR have been identified in a broad range of cell types including epithelial, endothelial, immune and structural cells. While CFTR has been investigated largely in the context of inborn dysfunction in cystic fibrosis, recent evidence shows that CFTR is also affected by acquired dysfunction in COPD. In patients with COPD and smokers, CFTR impairment has been demonstrated in the upper and lower airways, sweat glands and intestines, suggesting both pulmonary and systemic defects. Cigarette smoke, a key factor in COPD development, is the major cause of acquired CFTR dysfunction. Inflammation, bacterial byproducts and reactive oxygen species can further impair CFTR expression and function. CFTR dysfunction could contribute directly to disease manifestation and progression of COPD including disturbed airway surface liquid homeostasis, airway mucus obstruction, pathogen colonisation and inflammation. Mucus plugging and neutrophilic inflammation contribute to tissue destruction, development of dysfunction at the level of the small airways and COPD progression. Acquired CFTR dysfunction in extrapulmonary organs could add to common comorbidities and the disease burden. This review explores how CFTR dysfunction may be acquired and its potential effects on patients with COPD, particularly those with chronic bronchitis. The development of CFTR potentiators and the probable benefits of CFTR potentiation to improve tissue homeostasis, reduce inflammation, improve host defence and potentially reduce remodelling in the lungs will be discussed.
引用
- Mall MA, Criner GJ, Miravitlles M, et al. Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond. Eur Respir J. 2023. PMID: 37003609. doi:10.1183/13993003.01307-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。